Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)
TWD 41.8
(2.45%)
TWD 41.8
(2.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 342.6 Million | 369.18 Million | 556.62 Million | 151 Million | 386.19 Million | 366.12 Million |
| Net Income | 213.67 Million | 410.62 Million | 234.76 Million | 223.6 Million | 250.82 Million | 117.73 Million |
| Depreciation & Amortization | 181.96 Million | 176.28 Million | 179.75 Million | 185.28 Million | 192.99 Million | 196.2 Million |
| Deferred income taxes | - | - | - | - | 66 Thousand | - |
| Stock-based compensation | - | - | - | - | 10.13 Million | - |
| Change in working capital | -114.77 Million | -95.33 Million | 131.78 Million | -220.44 Million | -60.77 Million | 54.86 Million |
| Other non-cash items | 61.73 Million | -122.38 Million | 10.33 Million | -37.44 Million | -7.05 Million | -2.68 Million |
| Investing Cash Flow | -329.5 Million | -109.85 Million | -291.48 Million | -112 Million | -76.22 Million | -154.41 Million |
| Investments in PPE | -300.73 Million | -94.16 Million | -159.74 Million | -91.68 Million | -74.98 Million | -155.73 Million |
| Acquisitions | 6.52 Million | -89 Thousand | 46 Thousand | - | - | - |
| Investment purchases | -33.75 Million | -20 Million | -129.2 Million | -25.2 Million | - | - |
| Sales/Maturities of investments | -6.52 Million | 1.77 Million | 7.8 Million | - | - | - |
| Other Investing Activities | 4.97 Million | 2.62 Million | -10.38 Million | 4.88 Million | -1.24 Million | 1.32 Million |
| Financing Cash Flow | -35.76 Million | -275.31 Million | -114.47 Million | -164.47 Million | -94.56 Million | -386.65 Million |
| Debt repayment | -2.32 Billion | -2.93 Billion | -2.42 Billion | -3.15 Billion | -52 Million | -197.91 Million |
| Dividends payments | -201.97 Million | -156.53 Million | -151.48 Million | -121.18 Million | -90.06 Million | -161.58 Million |
| Common Stock Repurchased | -30.29 Million | -25.24 Million | -10.09 Million | -50.49 Million | 23.21 Million | -27.15 Million |
| Common Stock Issuance | 30.29 Million | 25.24 Million | 10.09 Million | 50.49 Million | 27.15 Million | 27.15 Million |
| Other Financing Activities | 2.48 Billion | 2.81 Billion | 2.46 Billion | 3.11 Billion | -2.86 Million | -27.15 Million |
| Accounts receivables | -66.77 Million | -38.53 Million | 29.75 Million | -4.09 Million | 9.88 Million | 24.45 Million |
| Accounts payables | -87.53 Million | 30.32 Million | 36.01 Million | -38.37 Million | 75.67 Million | 80.88 Million |
| Inventory | 71.52 Million | -130.21 Million | 80.12 Million | -189.05 Million | -160.07 Million | -76 Thousand |
| Other working capital | -31.99 Million | 43.08 Million | -14.1 Million | 11.08 Million | 13.74 Million | 54.93 Million |
| Cash at beginning of period | 401.2 Million | 417.12 Million | 266.46 Million | 391.95 Million | 176.55 Million | 351.49 Million |
| Cash at end of period | 378.47 Million | 401.2 Million | 417.12 Million | 266.46 Million | 391.95 Million | 176.55 Million |
| Capital Expenditure | -300.73 Million | -94.16 Million | -159.74 Million | -91.68 Million | -74.98 Million | -155.73 Million |
| Effect of forex changes on cash | -55 Thousand | 58 Thousand | -6000.00 | -13 Thousand | -3000.00 | 3000.00 |
| Net cash flow / Change in cash | -22.72 Million | -15.92 Million | 150.66 Million | -125.48 Million | 215.4 Million | -174.94 Million |
| Free Cash Flow | 41.87 Million | 275.02 Million | 396.88 Million | 59.32 Million | 311.21 Million | 210.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 44.13 Million | 70.14 Million | -74.23 Million | 213.67 Million | 65.45 Million | 107.8 Million |
| Depreciation & Amortization | 45.39 Million | 45.92 Million | 45.19 Million | 181.96 Million | 45.71 Million | 45.69 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -25.68 Million | -45.83 Million | 43.96 Million | -114.77 Million | -10.54 Million | -519 Thousand |
| Other non-cash items | 87.58 Million | 2.45 Million | 150.16 Million | 61.73 Million | -13.23 Million | -62.46 Million |
| Investing Cash Flow | -179.89 Million | 84.26 Million | -93.59 Million | -329.5 Million | -162.26 Million | -51.88 Million |
| Investments in PPE | -181.54 Million | -67.89 Million | -88.24 Million | -300.73 Million | -162.29 Million | -27.87 Million |
| Acquisitions | - | 15.9 Million | 1000.00 | 6.52 Million | - | 6.52 Million |
| Investment purchases | - | - | -2.97 Million | -33.75 Million | - | -30.77 Million |
| Sales/Maturities of investments | - | 135 Million | -1000.00 | -6.52 Million | - | -6.52 Million |
| Other Investing Activities | 1.65 Million | 1.25 Million | -2.37 Million | 4.97 Million | 36 Thousand | 6.76 Million |
| Financing Cash Flow | 133.51 Million | -310.5 Million | 3.51 Million | -35.76 Million | -82.5 Million | 53.45 Million |
| Debt repayment | -140 Million | -310 Million | -816.25 Million | -2.32 Billion | -540 Million | -956.25 Million |
| Dividends payments | - | - | - | -201.97 Million | -201.97 Million | - |
| Common Stock Repurchased | - | - | - | -30.29 Million | -30.29 Million | - |
| Common Stock Issuance | - | - | - | 30.29 Million | 232.27 Million | - |
| Other Financing Activities | -6.48 Million | -268 Thousand | 819.76 Million | 2.48 Billion | 457.49 Million | 1 Billion |
| Accounts receivables | 5.17 Million | -41.03 Million | -24.39 Million | -66.77 Million | -28.34 Million | 23.83 Million |
| Accounts payables | -16.86 Million | 42.85 Million | -9.47 Million | -87.53 Million | -22.15 Million | -59.56 Million |
| Inventory | 13.97 Million | 6.35 Million | 49.97 Million | 71.52 Million | 42.36 Million | 15.36 Million |
| Other working capital | -27.97 Million | -53.7 Million | 27.85 Million | -31.99 Million | -2.4 Million | 19.84 Million |
| Cash at beginning of period | 228.09 Million | 378.47 Million | 303.46 Million | 401.2 Million | 460.83 Million | 368.74 Million |
| Cash at end of period | 244.64 Million | 228.09 Million | 378.47 Million | 378.47 Million | 303.46 Million | 460.83 Million |
| Capital Expenditure | -181.54 Million | -67.89 Million | -88.24 Million | -300.73 Million | -162.29 Million | -27.87 Million |
| Effect of forex changes on cash | -1000.00 | - | -1000.00 | -55 Thousand | 1000.00 | - |
| Net cash flow / Change in cash | 16.55 Million | -150.38 Million | 75.01 Million | -22.72 Million | -157.37 Million | 92.09 Million |
| Free Cash Flow | -118.61 Million | 7.96 Million | 76.84 Million | 41.87 Million | -74.9 Million | 62.63 Million |
VIVC
2120
SSRM
6028
PD
4737